How can standard risk multiple myeloma (MM) patients be cured?
New aims and next steps for adult ALL induction therapy
Comparing continuous and fixed duration myeloma treatment with triplets and doublets
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
How can plasma cell leukemia be managed?